longbridgelongbridge
  • Platform Features
    Features
    Investment ProductsPrivate Wealth ManagementTrading ToolsMarket Data ServicesAnalysis ToolsNews ServicesFor Developers
    Account Types
    For IndividualsFor Institutions
  • Café
longbridge
© 2026 Longbridge|Terms of ServicePrivacy Policy

EBO

EBO
----

LongbridgeAI

EBOS Group Declares NZD 0.6367 Final Dividend and Activates Discounted DRP

Tip Ranks
Aug 19, 2026 at 01:47 AM
LongbridgeAII'm LongbridgeAI, I can summarize articles.

EBOS Group declared a final dividend of NZD 0.6367 per share for the six months ended June 2026, payable on September 18, 2026. The company activated its Dividend Reinvestment Plan (DRP), offering new shares at a 2% discount to the VWAP between August 31 and September 4. Analysts maintain a 'Buy' rating with a price target of NZ$24.50.

EBOS Group Limited ( (NZ:EBO) ) has provided an update.

EBOS Group Limited has declared a fully franked final dividend of NZD 0.615 per ordinary share for the six months to 30 June 2026, supplemented by an unfranked NZD 0.02170588 payment, bringing the total distribution to NZD 0.63670588 per share. The dividend will be paid on 18 September 2026 to shareholders on the register as of 28 August, with the ex-dividend date set for 27 August.

Australian holders will receive the AUD equivalent of the New Zealand dollar dividend, calculated on 11 September 2026 under the company’s currency arrangements. EBOS has confirmed that its Dividend Reinvestment Plan will apply in full to this distribution, with new shares issued at a 2 per cent discount to the NZX volume-weighted average price between 31 August and 4 September, reinforcing its capital management strategy and offering investors an alternative to cash.

The most recent analyst rating on (NZ:EBO) stock is a Buy
with a N$24.50 price target.
To see the full list of analyst forecasts on EBOS Group Limited stock,
see the NZ:EBO Stock Forecast page.

More about EBOS Group Limited

EBOS Group Limited is a healthcare and pharmaceutical distributor listed on the ASX, with ordinary fully paid shares trading under the ticker EBO. The company focuses on supplying medical and pharmacy products across Australia and New Zealand, serving a broad base of healthcare providers and retail pharmacies in both markets.

It also offers shareholders a Dividend Reinvestment Plan, allowing investors to convert cash dividends into additional shares at a discount to market price. This structure supports capital management while providing flexibility for investors seeking either income or long-term equity growth options.

Average Trading Volume: 211,296

Technical Sentiment Signal: Sell

Current Market Cap: N$4.39B

For an in-depth examination of EBO stock, go to TipRanks’ Overview page.

Login to unlock1,464characters for free

Due to copyright restrictions, please log in to your Longbridge account to view this content.
Thank you for your understanding and support of licensed content.

EBOS Group Limited

EBOS Group Limited

EBO.AU

Open

--

High

--

Low

--

Prev Close

--

P/ETTM

--

Market Cap

--